Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status

Genetic Epidemiology

Volumn 14, Issue 3, 1997, Pages 265-282

  Peacock, Rachel E ^a,c   Temple, Anne ^a   Gudnason, Vilmundur ^a   Rosseneu, Maryvonne ^b   Humphries, Steve E ^a,d  

^a Rayne Institute ^*  (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apolipoprotein gene polymorphism; Correlations; Haplotype; Lipids; Lipoprotein lipase; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN C3; DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENDER; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; ICELAND; MALE; NORMAL HUMAN; QUANTITATIVE TRAIT; SMOKING;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ICELAND; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; SEX FACTORS; SMOKING; STATISTICS, NONPARAMETRIC; VARIATION (GENETICS);

EID: 0030993006     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(1997)14:3<265::AID-GEPI5>3.0.CO;2-4     Document Type: Article

References (46)

1. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL (1992): Mechnism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice. J Clin Invest 90:1889-1900.
2. Ahn YI, Kamboh MI, Hamman RF, Ferrell RE (1993): Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res 34:421-427.
3. Bienvenu J, Deshaires P, Bernon H, Armanet P, Peristeris P, Lepape A, Perdrix JP (1988): Serum amyloid protein A (SAA) and HDL. Clinical implications and surgical resuscitation. Ann Biol Clin (Paris) 46:343-346.
4. Brunzell JD (1989): Familial lipoprotein lipase deficiency and other causes of the chlomicronemia syndrome. In Scriver CR, Beaudet AL, Sly WS, Valle D (eds): "The Metabolic Basis of Inherited Disease." New York: McGraw-Hill, pp 1165-1180.
5. Bury J, Rosseneu M (1985): Enzyme immunosorbent assay for human apolipoprotein C-III. J Clin Chem Biochem 23:63-68.
6. Catapano AL (1980): The distribution of apoCII and apoCIII in very low density lipoproteins of normql and type IV subjects. Atherosclerosis 35:419-424.
7. Chakravati A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH (1984): Non-uniform recombinatin within the human beta-globin gene cluster. Am J Hum Genet 36:1239-1258.
8. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J (1989): DNA polymorphisms at the lipoprotein lipase gene; associations in normo- and hypertriglyceridaemic subjects. Atherosclerosis 79:85-91.
9. Dammerman M, Sandkuiji LA, Halaas JL, Chung W, Breslow JL (1993): An apolipoprotein CIII haplo-type protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. PNAS USA 90:4562-4566.
10. Fielding CJ, Shore VG, Fielding PE (1972): A protein cofactor of lecithin:cholesterol acetyltransferase. Biochem Biophys Res Commun 46:1493-1498.
11. Friedewald WT, Levy RI, Fredrickson DS (1972): Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502.
12. Ginsberg, HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown VW (1986): Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 8:1287-1295.
13. Hata A, Robertson M, Emi M, Lalouel J-M (1990): Direct detection and automated sequencing of individual alleles after electrophoretic strand separation; identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acid Res 18:5407-5411.
14. Heizmann C, Ladias J, Antonarakis S, Kirchgessner T, Schotz M, Lusis AJ (1987): RFLP for the human lipoprotein lipase (LPL) gene; HindIII. Nucleic Acid Res 15:6763.
15. Heizmann C, Kirchgessner T, Kwiterovich PO, Ladiar JA, Derby C, Antonarakis SE, Lusis AJ (1991): DNA polymorphism haplotypes of the human lipoprotein lipase gene: Possible association with high density lipoprotein levels. Hum Genet 86:578-584.
16. Herbert PN, Assman G, Gatto AM JR, Fredrickson DS (1983): Familial lipoprotein deficiency. In Stanbury JB, Wyngaarden JB, Fredrickson DS (eds): "The Metabolic Basis of Inherited Disease," 5th ed. New York: McGraw-Hill, pp 589-621.
17. Humphries SE (1988): DNA polymorphisms of the apolipoprotein genes - Their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Atherosclerosis 72:89-108.
18. Jeenah MS, Wells C (1992): Fuctional significance of a point mutation in the apoAI promoter. Circulation 81:1-279.
19. Jeenah M, Kessling A, Miller N, Humphries SE (1990): G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med 7:233-241.
20. Kaprio J, Ferrell RE, Kottke BA, Sing CF (1989): Smoking and reverse cholesterol transport: Evidence for gene-environment interaction. Clin Genet 36:266-268.
21. Karathanasis SK (1985): Apolipoprotein multigene family: Tandem organization of apolipoprotein AI, CIII and AIV genes. Proc Natl Acad Sci USA 82:6374-6378.
22. Kessling A, Oullette S, Bouffard O, Chamberland A. Bétard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J (1991): Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: Influence of gender and exogenous hormones. Am J Hum Genet 50:92-106.
23. Kondo I, Berg K, Drayna D, Lawn R (1989): DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 35:49-56.
24. Mehrabian M, Lusis AJ ( 1992): Genetic markers for studies of atherosclerosis and related risk factors. In Lusis AJ, Rotter JI, Sparkes RS (eds.): "Molecular Genetics of Coronary Artery Disease." Monographs in Human Genetics, vol. 14. Basel: Karger pp 363-418.
25. Miller SA, Dykes DD, Polesky HF (1988): A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
26. Morrone G, Cortese R, Sorrentino V (1989): Post-transcriptional control of negative acute phase genes by transforming growth factor beta. EMBO J 8:3637-3671.
27. Paul-Hayase H, Rosseneu M, Robinson D, Van Vervliet JP, Deslypere JP, Humphries SE (1992): Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Hum Genet 88:439-446.
28. Peacock R, Hamsten A, Nilsson-Ehle P, Humphries S (1992): Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase acticvities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97:171-185.
29. Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P, Humphries SE (1994): Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clin Genet 46:273-282
30. Reichl D, Miller NE (1989): Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9:785-797.
31. Reilly SL, Ferrell, RE, Kottke BA, Kamboh MI, Sing CF (1991): The gender-specific apolipoprotein of lipids and apolipoprotein in the population of Rochester, MN. I. pleiotrophic effects on means and variances. Am J Hum Genet 49:1155-1166.
32. Saha N, Tay JSH, Low PS, Humphries SE (1994): G to A substitution in the promoter region of the apolipoprotein-AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet Epidemiol 11:255-264.
33. Sehayek E, Eisenberg S (1991): Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoporiteins through the low density lipoprotein receptor pathway. J Biol Chem 266:18259-18267.
34. Sigfusson N, Sigvaldason H, Steingrimsdottir L, Gudmundsdottir II, Stefansdottir I, Thorsteinsson T, Sigurdsson G (1991): Decline in ischaemic heart disease in Iceland and change in risk factor levels. Br Med J 302:1371-1375.
35. Sigurdsson G, Baldursdottir A, Sigvaldason H, Agnarsson U, Thorgeirsson G, Sigfusson N (1992a): The predictive value of apolipoproteins in a prospective survey for coronary heart disease in men. Am J Cardiol 69:1251-1254.
36. Sigurdsson G Jr, Gudnason V, Sigurdsson G, Humphries SE (1992b): Interaction between a polymorphism of the apolipoprotein AI promoter region and smoking determines plasma levels of high density lipoprotein and apolipoprotein AI. Arterioscler Thromb 12:1017-1022
37. Smith JD, Brinton EA, Breslow JL (1992): Polymorphism in the human apolipoprotein A-I gene promoter region: Association of the minor allele with decrased production rate in vivo and promoter activity in vitro. J Clin Invest 89:1796-1800.
38. Sokal RR, Rohlf FJ (1981): "Biometry," 2nd ed. New York: WH Freeman.
39. Sparkes RS, Zollman S, Klisak I, Kirchgessner TG, Komaromy MC, Mohandas T, Schotz MC, Lusis AJ (1987): Human genes involved in Lipolysis of plasma lipoproteins: Mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1:138-144.
40. Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E (1996): Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 16:941-947.
41. Talmud P, Humphries S on behalf of the EARS group (1994): A polymorphism in the promoter of the apolipoprotein AI gene associatedwith differences in apo AI levels. The European Atherosclerosis Research Study. Genet Epidemiol 11:265-280.
42. Taskinen M-R, Kussi T (1987): Enzymes involved in triglyceride hydrolysis. Baill Clin Endocrinol Metab 1:639-666.
43. Tuteja R, Tuteja N, Melo C, Casari G, Baralle FE (1992): Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occuring A to G transition. FEBS Lett 304:98-101.
44. Walsh A, Azrolan N, Wang K, Marcigliano A, O'Connell A, Breslow JL (1993): Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apoC-III gene. J Lipid Res 34:617-623.
45. Xu C-F, Angelico F, Del Ben M, Humphries S (1993): Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol 10:113-122.
46. Xu C-F, Talmud P, Schuster H, Houlston R, Miller G, Humphries S (1994): The association between genetic variation at the apo AI-CIII-AIV gene cluster and familial combined hyperlipidaemiaO. Clin Genet 46:385-397.